Endocrinology and Metabolic Disease

Doctor consulting with a patient during a metabolic health evaluation, representing Endocrinology and Metabolic Disease clinical research.

FOMAT Prime Therapeutic Areas provide highly specialized research sites with strong infrastructure, expert investigators, and proven recruitment models. In Endocrinology and Metabolic Disease, we support trials across NAFLD, MASH, obesity, diabetes, and related conditions with full diagnostic capabilities and access to diverse patients

0

Patients accessible through EMR

0

Metabolic sites with full capabilities

0

Advanced diagnostic technologies fully integrated

0 %

Diverse patient enrollment

Endocrinology Clinical Trials Capabilities

Our endocrinology clinical trials infrastructure is designed to handle complex protocols with consistency, making FOMAT a trusted partner for sponsors seeking operational efficiency

Dedicated SOPs and quality control processes for Endocrinology studies

Experienced staff managing metabolic trials across NAFLD, MASH, obesity, and diabetes

Multi-location patient access across California clinical sites

Integrated EHR, CTMS, eSource, eConsent, and remote monitoring systems

Specialized community engagement and recruitment teams targeting metabolic populations

Experienced research teams trained in advanced metabolic protocols and complex clinical trial execution

Key Differentiators

1

Reliable Start-Up Execution

Dedicated regulatory, contracting, and start-up teams streamline site activation and ensure predictable study launch timelines

2

Experienced Metabolic Investigators

Board-certified investigators with extensive clinical research experience in NAFLD, MASH, obesity, diabetes, and metabolic disorders

3

Real-Time Data Management

Integrated platforms (EHR, CTMS, eSource, eConsent) enable continuous data monitoring, query resolution, and sponsor access to clean, timely data

4

Comprehensive Recruitment & Retention

In-house patient engagement teams manage end-to-end recruitment, pre-screening, and retention processes across diverse metabolic populations

5

Infrastructure for All Study Phases

Fully equipped clinical sites support early-phase through late-phase metabolic trials with on-site diagnostics, imaging, and biospecimen capabilities

Specialized Sites for Metabolic Trials

Operationally built to support complex protocols